English
български
Español
Čeština
Dansk
Deutsch
Eesti keel
Ελληνικά
English
Français
Gaeilge
Hrvatski
Italiano
Latviešu valoda
Lietuvių kalba
Magyar
Malti
Nederlands
Polski
Português
Română
Slovenčina
Slovenščina
Suomi
Svenska
Sign in
Register
Commission Regulation (EU) 2023/699 of 29 March 2023 amending Council Regulation (EC) No 297/95 as regards the adjustment of the fees of the European Medicines Agency to the inflation rate with effect from 1 April 2023 (Text with EEA relevance)
Text
Chronology
Context
en
bg
es
cs
da
de
et
el
en
fr
ga
hr
it
lv
lt
hu
mt
nl
pl
pt
ro
sk
sl
fi
sv
Basic information
No longer in force
CELEX number:
32023R0699
Official Journal:
JOL_2023_092_R_0001
Form:
Regulation
Procedure number:
--
Languages:
bg
cs
da
de
el
en
et
fi
fr
ga
hr
hu
it
lv
lt
mt
nl
pl
pt
ro
sk
sl
es
sv
Dates
Date of document:
March 29, 2023
Date of publication:
March 30, 2023
Date of effect:
March 31, 2023
Entry into force - Date pub. +1 See Art 3
April 1, 2023
Application - See Art 3
Deadline:
April 1, 2023
See Art 2
Date of end of validity:
December 31, 2024
Implicitly repealed by
32024R0568
Modified by
Modifies
Modifies:
Council Regulation (EC) No 297/95 of 10 February 1995 on fees payable to the European Agency for the Evaluation of Medicinal Products
Affected by case
Legal basis
Council Regulation (EC) No 297/95 of 10 February 1995 on fees payable to the European Agency for the Evaluation of Medicinal Products
EuroVoc Vocabulary
European Medicines Agency
Internal market - Principles
Medicinal product
Inflation
Market approval
Proprietary medicinal products
Veterinary medicinal product